HBV cccDNA in patients' sera as an indicator for HBV reactivation and an early signal of liver damage

World Journal of Gastroenterology

Volumn 10, Issue 1, 2004, Pages 82-85

  Chen, Ying ^a   Sze, Johnny ^a   He, Ming Liang ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIINFECTIVE AGENT; CIRCULAR DNA; LAMIVUDINE; VIRUS DNA;

ARTICLE; DIAGNOSTIC KIT; DNA ISOLATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; LIVER INJURY; LONGITUDINAL STUDY; MEDICAL PARAMETERS; NONHUMAN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SERUM; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 0346055110     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i1.82     Document Type: Article

References (32)

1. He ML, Wu J, Chen Y, Lin MC, Lau GK, Kung HF. A new and sensitive method for the quantification of HBV cccDNA by realtime PCR. Biochem Biophys Res Commun 2002; 295: 1102-1107
2. Chen Y, Du Y, Chan CP, Tan YQ, Kung HF, He ML. Inhibition of hepatitis B virus (HBV) replication by stably-expressed shRNA. Biochem Biophys Res Commun 2003; 311: 398-404
3. Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 2003; 9: 641-644
4. Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001; 7: 445-454
5. Cai RL, Meng W, Lu HY, Lin WY, Jiang F, Shen FM. Segregation analysis of hepatocellular carcinoma in a moderately high-incidence area of East China. World J Gastroenterol 2003; 9: 2428-2432
6. Cao ZX, Chen XP, Wu ZD. Effects of splenectomy in patients with cirrhosis undergoing hepatic resection for hepatocellular carcinoma. World J Gastroenterol 2003; 9: 2460-2463
7. Wang NS, Wu ZL, Zhang YE, Guo MY, Liao LT. Role of hepatitis B virus infection in pathogenesis of IgA nephropathy. World J Gastroenterol 2003; 9: 2004-2008
8. Wang JY, Liu P. Abnormal immunity and gene mutation in patients with severe hepatitis-B. World J Gastroenterol 2003; 9: 2009-2011
9. Wang KX, Peng JL, Wang XF, Tian Y, Wang J, Li CP. Detection of T lymphocyte subsets and mIL-2R on surface of PBMC in patients with hepatitis B. World J Gastroenterol 2003; 9: 2017-2020
10. Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BQ, Li AM, Shi MF, Zou L. Interruption of HBV intrauterine transmission: A clinical study. World J Gastroenterol 2003; 9: 1501-1503
11. Wu CH, Ouyang EC, Walton C, Promrat K, Forouhar F, Wu GY. Hepatitis B virus infection of transplanted human hepatocytes causes a biochemical and histological hepatitis in immunocompetent rats. World J Gastroenterol 2003; 9: 978-983
12. Jaboli MF, Fabbri C, Liva S, Azzaroli F, Nigro G, Giovanelli S, Festi D, Reggiani LB, Roda E, Mazzella G. Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: Results of an open, controlled trial. World J Gastroenterol 2003; 9: 1491-1495
13. Wang Y, Liu H, Zhou Q, Li X. Analysis of point mutation in site 1896 of HBV precore and its detection in the tissues and serum of HCC patients. World J Gastroenterol 2000; 6: 395-397
14. Roussos A, Goritsas C, Pappas T, Spanaki M, Papadaki P, Ferti A. Prevalence of hepatitis B and C markers among refugees in Athens. World J Gastroenterol 2003; 9: 993-995
15. Peng XM, Chen XJ, Li JG, Gu L, Huang YS, Gao ZL. Novel assay of competitively differentiated polymerase chain reaction for screening point mutation of hepatitis B virus. World J Gastroenterol 2003; 9: 1743-1746
16. Song CZ, Bai ZL, Song CC, Wang QW. Aggregate formation of hepatitis B virus X protein affects cell cycle and apoptosis. World J Gastroenterol 2003; 9: 1521-1524
17. Yang X, Tang XP, Lei JH, Luo HY, Zhang YH. A novel stop codon mutation in HBsAg gene identified in a hepatitis B virus strain associated with cryptogenic cirrhosis. World J Gastroenterol 2003; 9: 1516-1520
18. Shen LJ, Zhang HX, Zhang ZJ, Li JY, Chen MQ, Yang WB, Huang R. Detection of HBV, PCNA and GST-pi in hepatocellular carcinoma and chronic liver diseases. World J Gastroenterol 2003; 9: 459-462
19. Yang SS, Hsu CT, Hu JT, Lai YC, Wu CH. Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral hepatitis B. World J Gastroenterol 2002; 8: 868-871
20. Zhuang L, You J, Tang BZ, Ding SY, Yan KH, Peng D, Zhang YM, Zhang L. Preliminary results of Thymosin-a1 versus interferon-alpha-treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B. World J Gastroenterol 2001; 7: 407-410
21. Lewin SR, Ribeiro RM, Walters T, Lau GK, Bowden S, Lacarnini S, Perelson AS. Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observed. Hepatology 2001; 34: 1012-1020
22. Lau GK, He ML, Fong DY, Bartholomeusz A, Au WY, Lie AK, Locarnini S, Liang R. Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation. Hepatology 2002; 36: 702-709
23. Hou CS, Wang GQ, Lu SL, Yue B, Li MR, Wang XY, Yu JW. Role of activation-induced cell death in pathogenesis of patients with chronic hepatitis B. World J Gastroenterol 2003; 9: 2356-2358
24. Yokosuka O, Omata M, Imazeki F, Okuda K, Summers J. Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: Analysis of intrahepatic replicative hepatitis B virus DNA. Hepatology 1985; 5: 728-734
25. Seeger C, Mason WS. Hepatitis B Virus Biology. Microb Molec Biol Review 2000; 64: 51-58
26. Summers J, Mason WS. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982; 29: 403-415
27. Jiang YG, Wang YM, Liu TH, Liu J. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B. World J Gastroenterol 2003; 9: 2221-2225
28. Fan CL, Wei L, Jiang D, Chen HS, Gao Y, Li RB, Wang Y. Spontaneous viral clearance after 6-21 years of hepatitis B and C viruses coinfection in high HBV endemic area. World J Gastroenterol 2003; 9: 2012-2016
29. Gaillard RK, Barnard J, Lopez V, Hodges P, Bourne E, Johnson L, Allen MI, Condreay P, Miller WH, Condreay LD. Kinetic analysis of wild-type and YMDD mutant hepatitis B virus polymerases and effects of deoxyribonucleotide concentrations on polymerase activity. Antimicrob Agents Chemother 2002; 46: 1005-1013
30. Tsiang M, Rooney JF, Toole JJ, Gibbs CS. Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy. Hepatology 1999; 29: 1863-1869
31. Zeuzem S, De Man RA, HonKoop P, Roth WK, Schalm SW, Schmidt JM. Dynamics of hepatitis B virus infection in vivo. J Hepatol 1997; 27: 431-436
32. Ni YH, Chang MH, Hsu HY, Chen HL. Long-term follow-up study of core gene deletion mutants in children with chronic hepatitis B virus infection. Hepatology 2000; 32: 124-128